Medik8 launches a new serum formulated with vegan, bioengineered PDRN, stepping into the competitive at-home skincare market dominated by treatments typically reserved for professional settings. The serum targets visible signs of aging and skin rejuvenation, positioning PDRN as an accessible alternative to in-clinic procedures.
PDRN, or polydeoxyribonucleotide, has gained traction in professional dermatology for its ability to stimulate collagen production and improve skin texture. By engineering a plant-derived version, Medik8 bypasses traditional salmon-derived PDRN while maintaining efficacy claims. This move reflects broader industry momentum toward vegan actives without sacrificing performance.
The formulation addresses a gap in the at-home skincare space. While Korean brands like Hada Labo and Cos de Baha have experimented with PDRN serums, luxury dermatological brands have largely kept advanced peptides and regenerative compounds in professional treatments. Medik8's entry signals confidence that consumers actively seek clinical-grade ingredients for home use, not just marketing narratives.
Bioengineered PDRN differs from traditional salmon extracts in sustainability and consistency. The lab-created version sidesteps overfishing concerns while delivering standardized concentrations batch to batch. For consumers with sensitivities to marine derivatives, this represents genuine utility beyond trend-chasing.
The brand's reputation in performance-driven skincare lends credibility here. Medik8 built its foundation on evidence-backed actives like vitamin C and retinol, avoiding hype-driven positioning. A PDRN serum from this house carries implicit clinical backing rather than celebrity endorsement weight.
Success hinges on price point and visible results within realistic timelines. Professional PDRN treatments